APA (7th ed.) Citation

Prapaporn Chaniad, Tachpon Techarang, Arisara Phuwajaroanpong, Walaiporn Plirat, Prasit Na-Ek, Atthaphon Konyanee, . . . Chuchard Punsawad. (2023). Preclinical evaluation of antimalarial activity of CPF-1 formulation as an alternative choice for the treatment of malaria. BMC.

Chicago Style (17th ed.) Citation

Prapaporn Chaniad, Tachpon Techarang, Arisara Phuwajaroanpong, Walaiporn Plirat, Prasit Na-Ek, Atthaphon Konyanee, Parnpen Viriyavejakul, Abdi Wira Septama, and Chuchard Punsawad. Preclinical Evaluation of Antimalarial Activity of CPF-1 Formulation as an Alternative Choice for the Treatment of Malaria. BMC, 2023.

MLA (9th ed.) Citation

Prapaporn Chaniad, et al. Preclinical Evaluation of Antimalarial Activity of CPF-1 Formulation as an Alternative Choice for the Treatment of Malaria. BMC, 2023.